deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02838628

Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp

A Phase 2a, Open-Label, Multicenter, Activity and Safety Study of KX2-391 Ointment 1% in Subjects With Actinic Keratosis on the Face or Scalp

Sponsor: Almirall, S.A.

Updated 11 times since 2017 Last updated: Mar 19, 2021 Started: Apr 11, 2016 Primary completion: Jan 11, 2017 Completion: Dec 22, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Actinic Keratosis, this trial is completed. The trial is conducted by Almirall, S.A. and has accumulated 11 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~May 2018 · 15 months · monthly snapshotActive Not Recruiting~May 2018 – ~Jun 2018 · 31 days · monthly snapshotActive Not Recruiting~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshotActive Not Recruiting~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshotUnknown Status~Feb 2019 – ~Jun 2020 · 16 months · monthly snapshotCompleted~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshotCompleted~Jan 2021 – ~May 2021 · 4 months · monthly snapshotCompleted~May 2021 – ~Jul 2024 · 38 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

11 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. May 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — May 2021 [monthly]

    Completed PHASE2

  5. Jun 2020 — Jan 2021 [monthly]

    Completed PHASE2

Show 6 earlier versions
  1. Feb 2019 — Jun 2020 [monthly]

    Completed PHASE2

    Status: Unknown StatusCompleted

  2. Jan 2019 — Feb 2019 [monthly]

    Unknown Status PHASE2

    Status: Active Not RecruitingUnknown Status

  3. Jun 2018 — Jan 2019 [monthly]

    Active Not Recruiting PHASE2

  4. May 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

  5. Feb 2017 — May 2018 [monthly]

    Active Not Recruiting PHASE2

  6. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Almirall, S.A.
  • Athenex, Inc.
Data source: Almirall, S.A.

For direct contact, visit the study record on ClinicalTrials.gov .